Morgan Stanley has projected a moderate upside for Chinese equities over the next year, driven by improved earnings, increased dominance in global upstream supply chains, and a strengthening yuan against the dollar.
The investment bank has set new price targets for various Chinese indexes for the second quarter of 2027: 28,400 for the Hang Seng, 91 for MSCI China, 9,900 for the HSCEI, and 5,400 for the CSI-300, indicating potential upsides of 8%, 12%, 11%, and 11%, respectively.
Strategists, led by Laura Wang, highlighted the significant opportunities within China's equity market, emphasizing the importance of solid fundamentals and promising themes that could enable investors to build a targeted portfolio that outperforms others.
They specifically pointed to stocks with strong technology and innovation capabilities, aligning with China's 15th Five-Year Plan, and those that could expand their global presence to meet energy demands. Additionally, they mentioned catalyst-driven stock ideas, including beneficiaries of U.S.-China summits and Southbound inclusion, as worthy of consideration.
Morgan Stanley noted that China's competitive supply chain positions it well in high-end power and green technology sectors, especially as global energy priorities shift due to the ongoing Middle East conflict.
The bank also anticipates that China's focus on tech localization, supported by policy initiatives in AI, semiconductors, and biotechnology, will be enhanced by the ongoing competition with the U.S. Furthermore, the upcoming meeting between Trump and Xi may yield some symbolic outcomes, such as trade relaxations and renewed discussions on issues like fentanyl and climate change.
Overall, Morgan Stanley believes that moderate index-level upside is achievable as investor attention returns to China, following distractions from the Middle East situation and the AI supercycle affecting neighboring markets